Magnetic Resonance Imaging Features in Triple-Negative Breast Cancer: Comparison With Luminal and HER2-Overexpressing Tumors

Paolo Belli; Melania Costantini; Daniela Distefano; Enida Bufi; Pierluigi Rinaldi; Maddalena Giuliani; Gianluigi Petrone; Stefano Magno; Lorenzo Bonomo; Md Matteo

doi:10.1016/j.clbc.2012.07.002

Magnetic Resonance Imaging Features in Triple-Negative Breast Cancer: Comparison With Luminal and HER2-Overexpressing Tumors

Paolo Belli, Melania Costantini, Daniela Distefano, Enida Bufi, Pierluigi Rinaldi, Maddalena Giuliani, Gianluigi Petrone, Stefano Magno, Lorenzo Bonomo, Md Matteo

Risultato della ricerca: Contributo in rivista › Articolo in rivista

47 Citazioni (Scopus)

Abstract

It has been ascertained that triple-negative (TN) breast cancer is characterized by an aggressive clinical course and a poor prognosis. The purpose of our study was to compare the magnetic resonance imaging (MRI) features of the 3 major different breast cancer subtypes (TN, luminal, and human epidermal growth factor receptor 2 [HER2]-overexpressing) and to suggest the criteria that might predict TN phenotype.

Lingua originale	English
pagine (da-a)	331-339
Numero di pagine	9
Rivista	Clinical Breast Cancer
Volume	12
DOI	https://doi.org/10.1016/j.clbc.2012.07.002
Stato di pubblicazione	Pubblicato - 2012

Keywords

N/A

Accesso al documento

10.1016/j.clbc.2012.07.002

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{e90204f2e2e6427d9d9ea18901d83b50,

title = "Magnetic Resonance Imaging Features in Triple-Negative Breast Cancer: Comparison With Luminal and HER2-Overexpressing Tumors",

abstract = "It has been ascertained that triple-negative (TN) breast cancer is characterized by an aggressive clinical course and a poor prognosis. The purpose of our study was to compare the magnetic resonance imaging (MRI) features of the 3 major different breast cancer subtypes (TN, luminal, and human epidermal growth factor receptor 2 [HER2]-overexpressing) and to suggest the criteria that might predict TN phenotype.",

keywords = "N/A, N/A",

author = "Paolo Belli and Melania Costantini and Daniela Distefano and Enida Bufi and Pierluigi Rinaldi and Maddalena Giuliani and Gianluigi Petrone and Stefano Magno and Lorenzo Bonomo and Md Matteo",

year = "2012",

doi = "10.1016/j.clbc.2012.07.002",

language = "English",

volume = "12",

pages = "331--339",

journal = "Clinical Breast Cancer",

issn = "1526-8209",

publisher = "Dallas, Tex. : Cancer Information Group, LP, c2000-",

}

Magnetic Resonance Imaging Features in Triple-Negative Breast Cancer: Comparison With Luminal and HER2-Overexpressing Tumors. / Belli, Paolo; Costantini, Melania; Distefano, Daniela; Bufi, Enida; Rinaldi, Pierluigi; Giuliani, Maddalena; Petrone, Gianluigi; Magno, Stefano; Bonomo, Lorenzo; Matteo, Md.

In: Clinical Breast Cancer, Vol. 12, 2012, pag. 331-339.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Magnetic Resonance Imaging Features in Triple-Negative Breast Cancer: Comparison With Luminal and HER2-Overexpressing Tumors

AU - Belli, Paolo

AU - Costantini, Melania

AU - Distefano, Daniela

AU - Bufi, Enida

AU - Rinaldi, Pierluigi

AU - Giuliani, Maddalena

AU - Petrone, Gianluigi

AU - Magno, Stefano

AU - Bonomo, Lorenzo

AU - Matteo, Md

PY - 2012

Y1 - 2012

N2 - It has been ascertained that triple-negative (TN) breast cancer is characterized by an aggressive clinical course and a poor prognosis. The purpose of our study was to compare the magnetic resonance imaging (MRI) features of the 3 major different breast cancer subtypes (TN, luminal, and human epidermal growth factor receptor 2 [HER2]-overexpressing) and to suggest the criteria that might predict TN phenotype.

AB - It has been ascertained that triple-negative (TN) breast cancer is characterized by an aggressive clinical course and a poor prognosis. The purpose of our study was to compare the magnetic resonance imaging (MRI) features of the 3 major different breast cancer subtypes (TN, luminal, and human epidermal growth factor receptor 2 [HER2]-overexpressing) and to suggest the criteria that might predict TN phenotype.

KW - N/A

UR - http://hdl.handle.net/10807/37874

U2 - 10.1016/j.clbc.2012.07.002

DO - 10.1016/j.clbc.2012.07.002

M3 - Article

VL - 12

SP - 331

EP - 339

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

SN - 1526-8209

ER -

Magnetic Resonance Imaging Features in Triple-Negative Breast Cancer: Comparison With Luminal and HER2-Overexpressing Tumors

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo